London, United Kingdom · Founded 2020 · Privately Held (backing)
Developer of a pipeline of therapeutics designed to transform large protein degraders into small molecules for targeted protein degradation. Kesmalea Therapeutics is based in London, United Kingdom and was founded in 2020. Its last known valuation is $39 million. It has raised $37.8 million.
These 3 firms already write checks for companies like Kesmalea Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.